Bruker (NASDAQ: BRKR) reported Q1 EPS of $0.49, $0.07 better than the analyst estimate of $0.42. Revenue for the quarter came in at $595 million versus the consensus estimate of $572.57 million.

GUIDANCE:

Bruker sees FY2022 EPS of $2.29-$2.33, versus the consensus of $2.29.

For earnings history and earnings-related data on Bruker (BRKR) click here.